Gsk Plc
Holdings as of Sep 30, 2026 · filed Nov 5, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Crispr Therapeutics Ag | $144297739 | 29.03% | -612208 | -19.01% |
| 2 | Vir Biotechnology Inc | $95599666 | 19.23% | — | Held |
| 3 | Wave Life Sciences Inc | $67509057 | 13.58% | — | NEW BUY |
| 4 | Biontech Se | $65716106 | 13.22% | -221298 | -24.87% |
| 5 | Ideaya Biosciences Inc | $51226654 | 10.31% | — | Held |
| 6 | Cytokinetics Inc | $22438005 | 4.51% | — | Held |
| 7 | Lyell Immunopharma Inc | $14808932 | 2.98% | — | Held |
| 8 | Spero Therapeutics Inc | $11120633 | 2.24% | — | Held |
| 9 | Nkarta Inc | $8254918 | 1.66% | — | Held |
| 10 | Fulcrum Therapeutics Inc | $6607142 | 1.33% | — | Held |
| 11 | Bicycle Therapeutics Plc | $5628784 | 1.13% | — | Held |
| 12 | Regenxbio Inc | $2044064 | 0.41% | — | Held |
| 13 | Cvrx Inc | $1763270 | 0.35% | — | Held |
Closed last quarter
Wave Life Sciences Ltd
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.